- Forums
- ASX - By Stock
- RMD
- Ann: ResMed Announces Results for the Fourth Quarter of FY2023
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-185
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$30.60 |
Change
0.095(0.31%) |
Mkt cap ! $19.38B |
Open | High | Low | Value | Volume |
$30.48 | $30.61 | $30.40 | $23.57M | 775.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1583 | $30.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$30.60 | 1944 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1016 | 30.590 |
4 | 862 | 30.580 |
8 | 1136 | 30.570 |
5 | 840 | 30.560 |
3 | 648 | 30.550 |
Price($) | Vol. | No. |
---|---|---|
30.600 | 1232 | 10 |
30.610 | 953 | 4 |
30.620 | 1109 | 3 |
30.630 | 454 | 4 |
30.640 | 346 | 3 |
Last trade - 10.53am 16/07/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online